Back

Assessing the best anticoagulation strategy for left ventricle thrombus after anterior myocardial infarction

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Advances in cardiovascular pharmacotherapy Anticoagulants HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Francisco Rodrigues Santos

Hospital Sao Teotonio, Viseu (Portugal)

5 More presentations in this session

Presentation thumbnail
Intravenous loop diuretic-induced decongestion in heart failure: an explorative study in a real-world population
Mr M. Erhardsson (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Incidence of erythrocytosis and thromboembolic risk in patients with heart failure and reduced ejection fraction treated with SGLT2 Inhibitors
Doctor A. Mohamed (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Efficacy and safety of sotagliflozin in patients with symptomatic obstructive and non-obstructive hypertrophic cardiomyopathy (SONATA-HCM): study design
Professor I. Olivotto (Florence, IT)
Abstract Slides Video
Presentation thumbnail
The impact of early SGLT2i inclusion in quadruple therapy for de novo patients: enhancing medication management and clinical outcomes
Doctor A. Esteban Fernandez (Leganes, ES)
Abstract Slides Video
Presentation thumbnail
Direct oral anticoagulants in patients with heart failure and atrial fibrillation: do we have an ideal score to predict major bleeding?
Doctor V. De Simone (Legnago, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Advances in cardiovascular pharmacotherapy

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
Anticoagulation for treatment of left ventricular thrombus: an systematic review and meta-analysis
thumbnail
Congress Presentation
Direct oral anticoagulants versus warfarin for left ventricular thrombus
thumbnail
Congress Presentation
Direct Oral Anticoagulants versus Vitamin K Antagonists for the management of left ventricular thrombus after myocardial infarction: A meta-analysis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources